Daclizumab Subcutaneous and Sandostatin LAR Depot
Determining the interaction of Daclizumab Subcutaneous and Sandostatin LAR Depot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Sandostatin LAR Depot injection
- Daclizumab Subcutaneous-Sani-Supp
- Daclizumab Subcutaneous-Sani-Supp rectal
- Daclizumab Subcutaneous-Sansert
- Daclizumab Subcutaneous-Santyl
- Daclizumab Subcutaneous-Saphris
- Sandostatin LAR Depot-Dacogen
- Sandostatin LAR Depot-Dacomitinib
- Sandostatin LAR Depot-Dactinomycin
- Sandostatin LAR Depot-Dactinomycin Injection
- Sandostatin LAR Depot-Dactinomycin Intravenous
- Sandostatin LAR Depot-Daklinza